PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Low-Dose Dexmedetomidine Bolus With Propofol for Pediatric MRI: Faster Recovery, More Bradycardia

dexmedetomidinepropofolalpha-2 adrenergic agonistpediatric sedationmagnetic resonance imagingtotal intravenous anesthesiabradycardiarandomized controlled trialnon-operating room anesthesiaoff-label use Pediatrics

Background Information

Dexmedetomidine as an adjunct shortens MRI sedation recovery in children.

Sedation for pediatric MRI must balance efficacy with safety, minimizing drug-related complications. Dexmedetomidine and propofol reduced recovery time to 19.4 minutes and required less propofol compared to propofol alone, with increased bradycardia risk. The study suggests potential practice changes in pediatric sedation for MRI but is limited by the increased bradycardia risk and study-specific protocol. Dexmedetomidine can enhance pediatric MRI sedation with faster recovery but monitor for bradycardia.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Dhanaboopathy K, Rai E, Williams A, Jose R, Rebekah G, Joselyn AS

Citation: Dhanaboopathy K, Rai E, Williams A, et al. Efficacy of dexmedetomidine as an adjuvant to propofol-based total intravenous anesthesia in children undergoing magnetic resonance imaging: A prospective randomized controlled trial. Journal of anaesthesiology, clinical pharmacology. 2026;42(4):572-577. doi:10.4103/joacp.joacp_557_25

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.